Novartis plans to cut 1,400 US sales jobs, as it reallocates resources
This article was originally published in Scrip
Executive Summary
Swiss Pharma Novartis plans to cut around 1,400 sales jobs at its US general medicines unit, beginning in early January, as it adjusts to pending patent expiries and continues strengthening its specialty care business.